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Synthesis and evaluation of a novel ionophore based 
on a thiacalix[4]arene derivative bearing imidazole 
units† 
Jiang-Lin Zhao,a Hirotsugu Tomiyasu,a Xin-Long Ni,b Xi Zeng,b Mark R. J. Elsegood,c 
Carl Redshawd and Takehiko Yamato*a 
O-Alkylation of the flexible thiacalix[4]arene 1 with 2-chloromethyl-1-methyl-1H-imidazole 2 
in the presence of Na2CO3 or K2CO3 afforded mono-O-alkylation product 3 in 29–51 % yield, 
along with recovery of the starting compound. In contrast, the same reaction in the presence of 
Cs2CO3 gave only one pure stereoisomer, namely 1,3-alternate-4; other possible isomers were 
not observed. Alkali metal salts such as Na2CO3 and Cs2CO3 can play an important role in the 
conformer distribution via a template effect. The conformations of the receptors, mono-O-
alkylation product 3 and that of 1,3-alternate-4, have been confirmed by X-ray 
crystallography. Furthermore, the complexation properties of the receptor 1,3-alternate-4 
toward selected alkali/transition metal cations are reported. The two-phase solvent extraction 
data indicated that 1,3-alternate-4 exhibited a stronger extraction efficiency for transition 
metals over alkali metals. The dichromate anion extraction ability of 1,3-alternate-4 showed 
that it could serve as an efficient extractor of HCr2O7−/Cr2O72− anions at low pH. 
Introduction 
Calix[n]arenes have attracted great attention as ionophoric 
receptors1 and potential enzyme mimics2 in host-guest 
chemistry. Over the past few decades, extensive research has 
been carried out to study and mimic biological systems such as 
enzymes, antibodies, and DNA by designing novel receptors.3 
Molecular recognition is a fundamental phenomenon in 
biology, and tuning of the affinity of a receptor for a ligand by 
the environment is key for the regulation of biological 
processes. With biomimetic receptors in mind, Reinaud et al. 
have recently developed the first supramolecular system that 
mimics metalloenzyme active sites by the selective binding of a 
neutral molecule to a metal center incorporated inside a tert-
butylcalix[6]arene functionalized at alternate positions by three 
imidazole groups.4 The imidazole unit is an essential metal 
binding site in metalloproteins. One or more imidazole units are 
bound to metal ions in almost all copper and zinc 
metalloproteins to bring about profound effects on their 
biological actions.5 In these metalloproteins the three-
dimensional structures of the macromolecules facilitate the 
coordination of metal ions by independent side-chain residues. 
Therefore, ligands containing two or more imidazole rings can 
potentially mimic the binding sites and catalytic activities of 
these enzymes.6 It was found by Reinaud et al.7 and by Huang 
et al.8 that calix[n]arenes can be converted to neutral ligands by 
the introduction of imidazole groups at the OH groups. They 
demonstrated that the metal selectivity was dependent on the 
calix[n]arene ring size and the systems exhibited remarkably 
high transition metal ion selectivity. Recently, it was found that 
receptors with imidazole groups bind anions by hydrogen 
bonding between the imidazolium rings and the guest anion.9 
Given that the ring size and flexibility are different between 
calix[4]arene and thiacalix[4]arene, it is interesting to assess 
what kind of ionophoric cavity tetra-thiacalix[4]arene 
imidazole-substituted compounds will provide. 
Chromium and its compounds are widely used in plating, 
leather tanning, dyes, cements, and in the photographic 
industry, all of which produces large quantities of toxic 
pollutants.10 High concentrations of hexavalent chromium ion is 
toxic to the human body, and to livestock. For example, a level 
of chromium i.e. >0.25 mg.L-1 is responsible for a serious threat 
to aquatic as well as human life in nearby areas.11 In nature 
Cr(VI) usually exists in the form of the acid radical, thus 
developing a positively charged ionophore for chromium has 
great research significance. 
To the best our knowledge, however, no precedent exists 
for molecular design of such tetrathiacalix[4]arene-based 
ionophores. Thus in this study, we aimed to synthesize tetra-
substituted tetrathiacalix[4]arene-bearing imidazole moieties at 
the lower rim in order to investigate their inclusion properties 
with metal ions. The tetrakis[2-(1-methyl-1H-imidazolyl) 
methoxy]-tetrathiacalix[4]arene with a 1,3-alternate 
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conformation, should have the appropriate encapsulating 
ionophilic cavity. 
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Scheme 1 O-Substitution reaction of tetraol 1 with 2-chloromethyl-1-methyl-
1H-imidazole 2.  
 
Table 1 O-Substitution reaction of tetraol 1 with 2-chloromethyl-1-methyl-
1H-imidazole 2. 
Na2CO3
Na2CO3
K2CO3
Cs2CO3
Run
1
2
3
4
Base Solvent
Acetone
MeCN
Acetone
Acetone
12
12
12
12
3 1,3-alternate-4
Yield
 
(%)
45
43
89
0
0
0
0
100
a, b
2/1
 
[mol/mol]
[66]
[30]
[29]
[51]
Recovery
 
of
 1
55
57
11
0
 
a The yield determined by 1H NMR spectroscopy. b Isolated yields are shown 
in square brackets. 
 
Results and discussions 
The thiacalix[4]arene derivatives 3 and 1,3-alternate-4 were 
synthesized by the method shown in Scheme 1. O-Alkylation of the 
flexible macrocycle 1 with 2-chloromethyl-1-methyl-1H-imidazole 
hydrochloride 2 in the presence of Na2CO3 in refluxing acetone or 
acetonitrile led to a mixture of unexpected compound 3 in (30 % and 
29 % yield, respectively) with a high recovery (55 % and 57 %, 
respectively) of the starting compound in spite of the conditions  (a 
large excess of 2-chloromethyl-1-methyl-1H-imidazole 
hydrochloride 2). A similar reaction carried out in the presence of 
K2CO3, afforded a higher yield (51 %) of compound 3, however 
possible isomers were still not observed (Scheme 1 and Table 1). 
The sole formation of compound 3 may be related to the following 
factors: the distance between the lone pair on the nitrogen atom and 
the smaller size Na+ or K+ was too long to allow for efficient 
binding. The reactivity of 2-chloromethyl-1-methyl-1H-imidazole 
hydrochloride 2 was sufficient for further alkylation of the 
imidazolyl group based on the thiacalix[4]arene, due to the existence 
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Fig. 1 Ring inversion of O-alkylation intermediate of tetraol 1 and 
immobilization by metal template. 
of a lone pair. Furthermore, as revealed by the results of an X-ray 
analysis, there exist two strong intramolecular hydrogen bonds 
between the hydroxyl groups and a phenolate oxygen O(3) of 
compound 3 (Fig. 2). Probably, these intramolecular hydrogen bonds 
(OH•••O–•••OH) were capable of holding a larger substituent in 
position that then obstructed access of another imidazole molecule to 
the reaction centre. When Na+ or K+ was employed as a base, the 
conformation was preferentially immobilized to the cone, the 
intramolecular hydrogen bonds could not be broken (Fig. 1 A), and 
so only the formation of compound 3 was possible. 
A much larger contribution by Cs+ to the template effect might 
be anticipated versus Na+, as reported by Harrowfield.12 The larger 
size of Cs+ could enable efficient binding with the lone pair of the 
nitrogen atom; the larger Cs+ might enlarge the radius of the 
cyclophane ring of tetraol 1 to form sufficient space to allow ring 
inversion and afford a thermodynamically stable 1,3-alternate 
conformer as illustrated in Fig. 1(B). The intramolecular hydrogen 
bonds are broken in the 1,3-alternate conformer. As a result, when 
Cs2CO3 was used as a base, only the tetra-substituted product 1,3-
alternate-4 was obtained in 66 % yield when using a large excess of 
2-chloromethyl-1-methyl-1H-imidazole hydrochloride 2. The 
expected isomer was finally observed (Scheme 1 and Table 1). 
 The structures of 3 and 1,3-alternate-4 were identified by 1H 
NMR, IR, MS spectra, elemental analyses and by X-ray 
crystallography. The 1H NMR spectrum of 3 showed three singlets 
for the tert-butyl protons (d 0.34, 1.18, and 1.34 ppm) and the 
relative intensity was 1: 1: 2 , indicating a mono-substituted structure 
for compound 3 (Fig. S1, see ESI†). Interestingly, it was found that 
two methyl protons for the ImmeCH3 were observed at d 3.78 (s, 3H) 
ppm and d 4.33 (s, 3 H) ppm, which strongly suggested that there 
were two imidazolyl groups present. Furthermore, the resonance for 
the methylene protons appeared as a singlet at d 6.05 (s, 2H) ppm, 
and an unexpected methylene group was observed as a singlet at an 
unusually down-field position (d 6.41 ppm, 2H). However, on 
consideration of the 1H NMR spectrum, there was only one possible 
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structure for compound 3, i.e., the mono-substituted cone structure. 
These observations strongly suggested that in compound 3 two of the 
imidazole rings were not di-substituted at two opposite O atoms of 
thiacalix[4]arene, rather the system was mono-substituted. In fact,  
 
 
 
 
 
 
 
 
 
 
Scheme 2 Synthesis of the reference compound 6. 
 
Table 2 Chemical shifts of 1,3-alternate-4 and reference compound 6.a 
Compound -N-Me H4 H5
1,3-alternate-4
6
∆db
2.51
3.70
+1.19
6.99
6.94
-0.05
6.69
6.82
+0.13
Chemical
 shif ts,
 
d
 
(ppm)
 
a ∆d value is the difference of the chemical shift between 1,3-alternate-4 and 
reference compound 6 in CDCl3 at 27 °C. b A plus sign (+) denotes a shift to 
lower magnetic field, whereas, a negative sign (-) denotes a shift to higher 
magnetic field. 
 
the second imidazole ring was bound to the first imidazolyl group, 
and the latter had been already appended to the thiacalix[4]arene, 
and had not separately bound to the opposite O atom of the 
thiacalix[4]arene.  
 In contrast, the 1H NMR spectrum of 1,3-alternate-4 showed a 
singlet for the tert-butyl protons at d 1.14 ppm, a singlet for 
ArOCH2Imme at d 5.17 ppm and a singlet for the aromatic protons at 
7.26 ppm, respectively, indicating a C4-symmmetric structure for the 
1,3-alternate-4 (Fig. S4, see ESI†). Interestingly, the heteroaromatic 
protons of the imidazole rings of 1,3-alternate-4 were exposed to the 
ring current shielding effect operated by the phenolic cyclophane 
ring of the parent scaffold, and were found to resonate at higher field 
compared to those of the reference compound 6, which was prepared 
by O-alkylation of 4-tert-butyl-2,6-dimethylphenol13 with 2-
chloromethyl-1-methyl-1H-imidazole hydrochloride in the presence 
of NaH (Scheme 2). Table 2 showed that the magnitude of this 
shielding, calculated as the difference between pertinent imidazole 
protons of 1,3-alternate-4 and reference compound 6, increased 
significantly at the H4 and N-Me protons. The remarkable shielding 
effect experienced by the H5 proton (–0.05 ppm) may be attributed to 
the repulsion between the nitrogen atoms in the imidazole rings.14 
X-ray crystallographic analyses confirmed the molecular 
structures of 3 and 1,3-alternate-4 as shown in Figures 2 and 3. The 
results for 3 confirmed that two of the imidazole rings were not  
 
 
(a) 
 
(b) 
 
Fig. 2 X-ray structure of compound 3 showing (a) the asymmetric unit 
including water and methanol of crystallisation, and (b) the upper-rim groups, 
viewed on to the calix-ring plane. Hydrogen atoms have been omitted for 
clarity except for those involved in H-bonding or on solvent of 
crystallisation. 
 
disubstituted at two opposite O atoms of thiacalix[4]arene, but that 
mono-substitution had occurred. The second imidazole ring was 
bound to the first imidazolyl group which had been fixed to the 
thiacalix[4]arene, and not to the opposite O atom. O(3) bears a 1– 
charge and H-bonds to two adjacent phenolic groups. N(2) bears a 
1+ charge. Rings at O(1) and O(3) were pinched in {C(4)···C(24) = 
6.062(3)Å}, while those at O(2) and O(4) were splayed out 
{C(14)···C(34) = 9.965(3)Å}. The most noteworthy feature was the 
extent to which the ring at O(3) was bent in to fill the unsually wide 
open thiacalix[4]arene cavity, and thus the thiacalix[4]arene was 
very distorted. The asymmetric unit comprises one thiacalixarene 
molecule, one methanol and two waters of crystallisation (Fig. 2). 
 For 1,3-alternate-4, the molecule resides on the 4 axis, so one 
quarter is unique. Two imidazolyl groups in the compound point 
upwards, with the another two pointing downwards. Interestingly, 
ARTICLE Journal Name 
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
the four imidazolyl groups are kept away from the cavity; the 
shortest distance between the carbon of the N–Me and the carbon of 
the phenyl ring is 3.48 Å (e.g. C(15) – C(1)). Given this, the two 
phenyl rings which are face-to-face are almost parallel, and form a 
square cavity with C(4)···C(4’) = 5.998(4)Å. All of the adjacent S–S 
distances are about 5.54 Å, the S–S–S bond angle is about 89.76° 
(Fig. 3). 
 
 
(a) 
 
(b) 
Fig. 3 X-ray structure of compound 1,3-alternate-4 showing (a) the side view 
(b) the upper-rim groups, viewed on to the calix-ring plane. Hydrogen atoms 
have been omitted for clarity in (a). 
 
 In order to investigate the ionophoric affinity of 1,3-alternate-4 
for metal cations, the extractability of the metal ions was determined 
by solvent extraction from the aqueous to the organic phase. We 
noted that the extraction of transition metals was higher than the 
extraction of alkali metals by 1,3-alternate-4 (Fig. 4). This might be 
due to the transition metals having a higher nuclear charge and 
smaller radius. The free d orbitals of the transition metals are capable 
of accepting lone pairs from the ligand, and given the electron 
configuration of the metal, it is easy to feedback d electrons to the 
ligand. In this experiment, ligand 4 had lone pairs of electrons for 
donation (providing the nitrogen atoms), and therefore was able to  
 
 
Fig. 4 Extraction percentages of metal picrates with 1,3-alternate-4  ([Host] = 
2.5 × 10–4 M in CH2Cl2, [Guest] = 2.5  × 10–4 M in water at 25 °C). 
 
form stable complexes. However, alkali metal and alkaline earth 
metals, in contrast to the transition metal, have low polarization, 
with an inert gas structure, poor ability to form complexes, and the 
stability of their complexes was poor. 
Due to the existence of three metal-binding sites, including the 
parent cavities, the 1,3-substituted as well as 2,4-substituted 
imidazole moieties, there were several possibilities for metal 
complexation in the 1,3-alternate-4 with guest molecules and 1 : 1 or 
1 : 2 metal complexation might well be possible. Therefore, the 
continuous variation Job’s plot method was applied to determine the 
stoichiometries of 1,3-alternate-4 with Ag+ ions as an example in a 
two-phase extraction experiment (H2O–CH2Cl2). The percentage 
extraction for 1,3-alternate-4 (Job plot) supported the formation of a 
1 : 2 complex with Ag+ cations. When 1,3-alternate-4 and Ag+ 
cation concentrations were changed systematically, the percentage 
extraction reached a maximum between 0.6 and 0.7 mole, which 
indicated that 1,3-alternate-4 formed a 1 : 2 complex with Ag+ 
(Fig.5). 
Furthermore, in order to look further into the binding  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Job plot for complexation of 1,3-alternate-4 with Ag+ ion.  
Mole
 
f raction
 of
 
[Ag+]
 
/
 
([1,3
-alternate-4]+[Ag+])
∆ A
Journal Name ARTICLE 
This journal is © The Royal Society of Chemistry 2012 J. Name., 2012, 00, 1-3 | 5  
 
 
(a)
(b)
(c)
d/ppm
Imidazolyl-Me
Fig. 6 1H NMR spectral changes of 1,3-alternate-4 (8 × 10−3 M) on addition 
of AgClO4 (300 MHz, CDCl3:CD3CN = 10 : 1, [1,3-alternate-4] = 8 × 10−3 
M ). (a) Free 1,3-alternate-4; (b) in the presence of 1.0 equiv. of AgClO4; (c) 
in the presence of 2.0 equiv. of AgClO4.  
properties of the receptor 1,3-alternate-4 with Ag+, 1H NMR 
titration experiments were carried out in CD3Cl:CD3CN = 10 : 1 
solution. The chemical shift changes for compound 1,3-alternate-4 
on complexation with Ag+ are illustrated in Fig. 6. Significant 
change was observed for the imidazole-N-CH3 protons after 
complexation of 1,3-alternate-4 with 1.0 equiv. Ag+; the chemical 
shift of the methyl group shifted dramatically downfield by + 1.11 
ppm at d 3.65 ppm (complexation) and + 0.11 ppm at d 2.65 ppm 
(uncomplexed) as two broad singlets. On increasing the titration 
amount of Ag+ to 2.0 equiv., a clear singlet at d 3.69 ppm was 
observed, which belonged to the methyl group. This chemical shift 
was almost same as the methyl group of reference compound 6. The 
adjacent imidazolyl-proton H4 was affected by the change of N–CH3, 
and exhibited a shift downfield by + 0.52 ppm at d 7.22 ppm. These 
changes strongly suggested that Ag+ was complexed by the 
imidazole moieties via N⋯Ag+ interactions with these nitrogen 
atoms oriented outwards to inwards. These results also indicated that 
Ag+ was complexed by all four imidazole moieties of the 1,3-
alternate-4, and a 1 : 2 complex was formed with retention of the 
original symmetry (conformationally frozen on the NMR time scale). 
To better understand the chelating effect of imidazole fragments 
in the Ag+ cation binding, the complexation Ag+ by the host 1,3-
alternate-4 is shown in Fig. 7. From the results of the X-Ray 
analysis, the four imidazolyl groups are kept away from the cavity, 
the N–CH3 of imidazolyl groups are close to the outward pointing 
phenyl ring, and the shortest distance between the carbon of N–CH3 
and the ipso carbon of phenyl ring is 3.48 Å (e.g. C(15) – C(1)). 
Interestingly, when 1.0 equiv. Ag+ was added to the solution of 1,3-
alternate-4, two imidazole groups captured one silver cation via 
N⋯Ag+ interactions, and this led to these imidazole groups being 
oriented inwards towards the cavity. Under these conditions, the 
imidazole-N–CH3 was removed from the shielding area to the 
deshielding area, and the chemical shift of the N–CH3 proton 
recovered to d 3.65 ppm. When 2.0 equiv. Ag+ was added, a similar 
phenomenon was observed in the other two imidazole groups. 
A preliminary evaluation of the anion binding efficiencies 
of the potential extractant 1,3-alternate-4 has been carried out 
by solvent extraction of K2Cr2O7 from aqueous solution into 
dichloromethane at different pH values as reported 
previously.15a From the extraction results given in Fig. 8, it was 
clear that 1,3-alternate-4 was effective for the extraction of 
dichromate anions at low pH. This could be attributed to an ion-
pair (hydrogen bonded) complex formed in the two-phase 
extraction system following proton transfer to the nitrogen 
atoms of the imidazole units in 1,3-alternate-4 and then 
complexation of Cr2O72−/HCr2O7−.14 However, the reference 
compound 6 showed almost no significant selective binding of 
dichromate anions even at low pH. Based on these results, it is 
concluded that the thiacalix[4]arene unit plays an important role 
in confirming cooperative participation of the peripheral 
imidazole groups. 
The evaluation of dichromate anion extraction efficiencies 
by calix[n]arene derivatives has rarely been studied over the 
past decade.14,15 When higher concentrations of ligands (10 
equiv.) to dichromate anions were employed in the extraction 
experiment, the maximum extraction efficiencies were 
81.8 %,15a 23.0 %,15b 86.6 %,15c 72.0 %,15d 69.4 %15e and 
73.7 %15f at lowest pH. However, 1,3-alternate-4 exhibited 
outstanding extraction ability for dichromate anions, with the 
maximum percentage of extracted dichromate ions found to be 
70.4 % for 1,3-alternate-4 at a lower concentration (2 equiv.) 
when the pH of the aqueous solution was 1.5 (Fig. 8). In other 
words, 1,3-alternate-4 can serve as a highly effective extractant 
for the extraction of dichromate anions (Cr2O72−/HCr2O7−). 
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Fig. 7 Binding modes of 1,3-alternate-4 with Ag+. 
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Fig. 8. Extraction percentages of dichromate anion with 1,3-alternate-4 
and reference 6 at pH 1.5–7.0 (H2O/CH2Cl2:10/10 (v/v); K2Cr2O7 = 1 × 
10−4 M; ligand: (a) reference 6, 4.0 × 10−4 M; (b) 1,3-alternate-4, 0.5 × 
10−4 M; (c) 1,3-alternate-4, 1.0 × 10−4 M; (d) 1,3-alternate-4, 2.0 × 10−4 
M; (e) 1,3-alternate-4, 4.0 × 10−4 M, 1 h at 25 °C). 
 
Conclusion 
O-Alkylation of the flexible macrocycle thiacalix[4]arene 1 with 2-
chloromethyl-1-methyl-1H-imidazole 2 in the presence of Na2CO3 or 
K2CO3 afforded the mono-O-alkylation product 3 in 29–51 % yield 
along with recovery of the starting compound. In contrast, the same 
reaction in the presence of Cs2CO3 gave only one pure stereoisomer 
1,3-alternate-4, whilst the other possible isomers were not observed. 
Alkali metal cations can play an important role in the conformer 
distribution based on the template effect. Variation of the alkylation 
conditions and reagents can lead to the derivatives with different 
conformations, which can serve as interesting building blocks for 
larger potential host molecules. The present new imidazole-
substituted thiacalix[4]arene framework can effectively extract 
transition metal cations. The two-phase solvent extraction data indi-
cated that the extraction of transition metals by tetrakis[2-(1-methyl-
1H-imidazolyl)methoxy]thiacalix[4]arene 1,3-alternate-4 was higher 
than the extraction of alkali metals. The results of the dichromate 
anion extraction for 1,3-alternate-4 showed that it can serve as a 
highly effective extractor for dichromate anions (Cr2O72−/HCr2O7−). 
Experimental Section 
General  
All melting points were determined using a Yanagimoto MP-S1. 
1H-NMR spectra were determined at 300 MHz with a Nippon 
Denshi JEOL FT-300 NMR spectrometer with SiMe4 as an 
internal reference; J-values are given in Hz. IR spectra were 
measured as KBr pellets or as liquid films on NaCl plates in a 
Nippon Denshi JIR-AQ2OM spectrophotometer. UV spectra 
were measured by a Shimadzu 240 spectrophotometer. Mass 
spectra were obtained on a Nippon Denshi JMS-01SG-2 mass 
spectrometer at an ionization energy of 70 eV using a direct 
inlet system through GLC. Elemental analyses were performed 
by a Yanaco MT-5. G.L.C. analyses were performed with a 
Shimadzu gas chromatograph. 
Materials 
5,11,17,23-Tetra-tert-butyl-2,8,14,20-tetrathiacalix[4]arcne-
25,26,27,28-tetraol l was prepared from p-tert-butylphenol 
according to the reported procedure.16 
 
O-Alkylation of 1 with 2-chloromethyl-1-methyl-1H-imidazole 2 
in the presence of Na2CO3.  
A mixture of 1 (300 mg, 0.417 mmol) and Na2CO3 (885 mg, 8.34 
mmol) in dry acetone or acetonitrile (50 mL) was heated at reflux for 
1 h. Then 2-chloromethyl-1-methyl-1H-imidazole hydrochloride (2) 
(835 mg, 5.0 mmol) was added and the mixture heated at reflux for 
24 h under argon. After cooling the reaction mixture to room 
temperature, it was filtered. The filtrate was concentrated and the 
residue was acidified with a 10 % HCl solution and extracted with 
CH2Cl2 (30 mL
 × 3), and the organic phase was washed with water 
(40 mL × 2) and then brine (40 mL). The organic phase was dried 
over MgSO4. The filtrate was evaporated to give a yellow oil, which 
was then washed with MeOH and hexane to give compound 3 (in 
acetone, 116 mg, 30 %) and (in acetonitrile, 112 mg, 29 %) as a 
white solid. Recrystallized from CHCl3:MeOH (3:1) afforded mono-
substituted-3 as colourless prisms. M.p. 212–214 °C. IR νmax 
(KBr)/cm-1 3374, 2961, 2867, 1635, 1586, 1557, 1536 and 1361; 1H 
NMR (300 MHz, CDCl3): δ = 0.34 (s, 9H, tBu), 1.18 (s, 9H, tBu), 
1.34 (s, 18H, tBu), 3.78 (s, 3H, NCH3), 4.33 (s, 3H, NCH3), 6.05 (s, 
2H, ArO–CH2–Imme), 6.41 (s, 2H, Imme–CH2–Imme), 6.87 (s, 1H, 
Imme–H), 6.92 (s, 2H, Imme–H), 6.99 (s, 1H, Imme–H), 7.38 (s, 1H, 
Ar–H), 7.47 (s, 2H, Ar–H), 7.60 (s, 2H, Ar–H), 7.65 (s, 3H, Ar–H) 
and 7.67 (s, 1H, OH) ppm. 13C NMR (CDCl3) d = 29.9, 31.6, 33.4, 
33.5, 33.6, 34.0, 36.8, 44.7, 56.8, 121.7, 122.5, 123.1, 123.3, 123.9, 
124.5, 127.8, 128.3, 131.9, 133.8, 134.3, 136.3, 136.8, 139.8, 140.7, 
143.6, 148.4, 152.5, 157.9 and 166.1 ppm. FABMS: m/z 909.42 
(M+). Anal. Calcd. for C51H68N4O7S4 (977.33): C 62.68, H 7.01, N 
5.73. found: C 62.68, H 6.83, N 5.80.  
O-Alkylation of 1 with 2-chloromethyl-1-methyl-1H-imidazole 2 
in the presence of K2CO3.  
A mixture of 1 (300 mg, 0.417 mmol) and K2CO3 (1.15 g, 8.34 
mmol) in dry acetone (50 mL) was heated at reflux for 1 h. Then 2-
chloromethyl-1-methyl-1H-imidazole hydrochloride (2) (835 mg, 
5.0 mmol) was added and the mixture heated at reflux for 24 h under 
argon. After cooling the reaction mixture to room temperature, it was 
filtered. The filtrate was concentrated and the residue was acidified 
with a 10 % HCl solution and extracted with CH2Cl2 (30 mL
 × 3), 
and the organic phase was washed with water (40 mL × 2) and then 
brine (40 mL). The organic phase was dried over MgSO4. The 
filtrate was evaporated to give a yellow oil, which was then washed 
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with MeOH and hexane to give compound 3 (193 mg, 51 %) as a 
white solid. Recrystallized from CHCl3 : MeOH (3:1) afforded 
mono-substituted-3 as colourless prisms.  
O-Alkylation of 1 with 2-chloromethyl-1-methyl-1H-imidazole 2 
in the presence of Cs2CO3.  
A mixture of 1 (300 mg, 0.417 mmol) and Cs2CO3 (2.72 g, 8.34 
mmol) in dry acetone (50 mL) was heated at reflux for 1 h. Then 2-
chloromethyl-1-methyl-1H-imidazole hydrochloride (2) (835 mg, 
5.0 mmol) was added and the mixture heated at reflux for 24 h under 
argon. After cooling the reaction mixture to room temperature, it was 
filtered. The filtrate was concentrated and the residue was acidified 
with a 10 % HCl solution and extracted with CH2Cl2 (30 mL
 × 3), 
and the organic phase was washed with water (40 mL × 2) and then 
brine (40 mL). The organic phase was dried over MgSO4. The 
filtrate was evaporated to give a yellow oil, which was then washed 
with MeOH and hexane to give 1,3-alternate-4 (300 mg, 66 %) as a 
white solid. Recrystallization from CH2Cl2-MeCN (3:1) afforded 
1,3-alternate-4 as colourless prisms. M.p. 259–261 °C; IR: νmax 
(KBr)/cm-1: 3056, 2961, 2906, 2870, 1635, 1574 and 1529; 1H NMR 
(300 MHz, CDCl3) d = 1.41 (s, 36H, tBu), 2.51 (12H, s, NCH3), 5.17 
(s, 8H, ArOCH2Imme), 6.69 (s, 4H, Imme–H), 6.99 (s, 4H, Imme–
H) and 7.26 (8H, s, Ar–H) ppm. 13C NMR (CDCl3) d = 31.5, 32.8, 
34.4, 64.5, 122.2, 127.3, 128.9, 129.7, 143.2, 147.9 and 156.2 ppm. 
FABMS: m/z: 1097.46 (M+). Anal. calcd for C60H72N8O4S4 
(1096.46): C 65.66, H 6.61, N 10.21. found: C 65.68, H 6.73, N 
10.18. 
Stoichiometry of metal complexation 
The method of continuous variation was employed to determine 
the stoichiometry in the complexes involving the host 1,3–
alternate-4. Two-phase solvent extraction was carried out 
between aqueous picrates (5 mL, [metal picrate] = 2.5 × 10-4 M) 
and host (5 mL, [host] = 2.5 × 10-4 M in CH2Cl2). The two 
phase mixture in a glass tube was immersed in a thermostated 
water bath at 25 °C which was shaken at 300 strokes per min 
for 1 h and then kept at the same temperature for 2 h, allowing 
the complete separation of the two phases. This was repeated 3 
times. The absorbance of each solution was determined by UV 
spectroscopy (λ = 290 nm). The molar ratios of both the host 
and metal picrate were varied from 0 to 1, while the total 
concentration was kept at several constant levels. Job plots 
were generated by plotting the extracted [M+] versus the mole 
fraction of metal. We confirmed that this period was sufficient 
to attain the distribution equilibrium. The extractability was 
determined spectrophoto-chemically from the decrease in the 
absorbance of the picrate ion in the aqueous phase, as described 
by Pedersen.17 
1H-NMR complexation experiments  
To a CDCl3/CD3CN (v/v 10:1, 8 × 10‒3 M) solution of 1,3-alternate-
4 in an NMR tube was added a CDCl3/CD3CN (v/v 10:1, 4 × 10‒3 M) 
solution of AgClO4. The spectra were recorded after the addition and 
the temperature of the NMR probe was kept constant at 27 °C. 
Crystallographic analyses of  3 and 1,3-alternate-4 
Diffraction data were collected on a Bruker APEX 2 CCD 
diffractometer equipped with graphite-monochromated Mo-Kα 
radiation at 150(2)K.18 Data were corrected for Lorentz and 
polarisation effects and for absorption.18 The structures were solved 
by direct methods and refined by full-matrix least-squares methods, 
on F2.19 H atoms were refined using a riding model except for those 
on hetero atoms in 3 which were freely refined. In 3 the entrire tBu 
group at C(7) was refined as two-fold disordered with major 
componente occupancy of 59.2(7)%, while tBu groups at C(27) and 
C(37) were modelled with the methyl groups two-fold disordered 
with major occupancies of 53.7(6) and 85.5(6)% respectively. 
Crystal data for 3: C51H68N4O7S4, M = 977.33. Orthorhombic, space 
group Pbca, a = 13.2947(5), b = 21.6351(9), c = 37.7271(15) Å, V = 
10851.5(7) Å3. Z = 8, Dc = 1.196 g.cm–3, F(000) = 4176, T = 150(2) 
K, μ(Mo-Kα) = 0.226 cm–1, λ(Mo-Kα) = 0.71073 Å, colourless 
crystal of size 0.67 × 0.25 × 0.10 mm3. The total number of 
reflections measured, to θmax = 27.20°, was 98199 of which 12054 
were unique (Rint = 0.0537); 8953 were ‘observed’ with I > 2σ(I). 
For the ‘observed’ data only, R1 = 0.0497; wR2 = 0.1426 for all 
12054 reflections and 715 parameters. Residual electron density 
within +/– 0.621 eÅ–3. 
Crystal data for 1,3-alternate-4: Crystal data: C60H72N8O4S4, M = 
1097.50. Tetragonal, space group, I41/a, a = 19.530(2), c = 
15.3376(16) Å, V = 5849.8(10) Å3. Z = 4, Dc = 1.246 g.cm–3, 
F(000) = 2336, T = 150(2) K, μ(Mo-Kα) = 0.215 cm–1, λ(Mo-Kα) = 
0.71073 Å. Colourless Crystal of size 0.24 × 0.12 × 0.10 mm3. The 
total number of reflections recorded, to θmax = 27.20 °, was 25807 of 
which 3254 were unique (Rint = 0.0776); 2220 were ‘observed’ with 
I > 2σ(I). For the ‘observed’ data only, R1 = 0.0401; wR2 = 0.0899 
for all 3254 reflections. Residual electron density within +/– 0.291 
eÅ–3. 
 Crystallographic data (excluding structure factors) for the 
structures in this paper have been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication numbers 
CCDC 997019 for 3 and 997001 for 1,3-alternate-4, respectively. 
Copies of the data can be obtained, free of charge, on application to 
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: 144-1223-
336033 or e-mail: deposit@ccdc.cam.ac.uk]. 
Supporting information: 1H, 13C NMR & IR spectra of 
compound 3 and 1,3-alternate-4.  
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